CA
EOLS icon

Clearstead Advisors’s Evolus EOLS Stock Holding History

Clearstead Advisors’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119 Sell
17
-17
-50% -$100 ﹤0.01% 3325
2026
Q1 		$141 Hold
34
– – ﹤0.01% 2188
2025
Q4 		$228 Buy
+34
New +$230 ﹤0.01% 2404

Other funds holding EOLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $2.19B AUM 23.13% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Clearstead Advisors's EOLS Position: Q2 2026 in Review

Clearstead Advisors reduced its Evolus (EOLS) stake by 50% in Q2 2026, selling an estimated $100 and leaving 17 shares worth $119. The position accounts for ﹤0.01% of the portfolio, ranked #3325.

Clearstead Advisors first reported a position in EOLS in Q4 2025 and has held it in 3 quarters since. The position peaked at $228 in Q4 2025. 52 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Clearstead Advisors held 17 shares of Evolus worth $119 as of Q2 2026.
  • Clearstead Advisors sold 17 Evolus shares in Q2 2026, an estimated $100.
  • Evolus made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3325 holding.
  • Clearstead Advisors first reported a position in Evolus in Q4 2025 and has held it in 3 quarters since.
  • Clearstead Advisors's Evolus position peaked at $228 in Q4 2025.
  • 52 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.